DEFB107A in The Immune Response and Its Potential as A Drug Target Or Biomarker

Target Name: DEFB107A

NCBI ID: G245910

DEFB107A

DEFB107A in The Immune Response and Its Potential as A Drug Target Or Biomarker

DEFB107A, also known as beta-Defensin 107 (BD107), is a protein that is expressed in a variety of tissues, including the skin, lungs, heart, kidneys, and intestines. It is a member of the defensin family of proteins, which are involved in the immune response. While the exact function of BD107A is not yet fully understood, it is known to play a role in the regulation of inflammation and infection. As a potential drug target or biomarker, BD107A is of interest to researchers because of its potential utility in the development of new treatments for a variety of diseases.

The Defensin Family

The defensin family of proteins is characterized by the presence of a conserved region that includes a N-terminal transmembrane domain, a cytoplasmic tail, and a C-terminal region that is involved in interactions with other proteins. This conserved region is responsible for the unique structure and function of each member of the defensin family.

BD107A is a member of the defensin family and is expressed in a variety of tissues, including the skin, lungs, heart, kidneys, and intestines. It is a 14kDa protein that has a calculated molecular weight of 19,112.BD107A has a single copy of each of the conserved regions found in the defensin family, and these regions are responsible for the unique structure and function of the protein.

Function and Interaction

While the exact function of BD107A is not yet fully understood, it is known to play a role in the regulation of inflammation and infection. BD107A has been shown to be involved in the regulation of cellular immune responses, including the regulation of T cell responses. It has also been shown to play a role in the regulation of inflammation and infection, including the regulation of the complement system.

In addition to its role in the immune response, BD107A may also be a potential drug target or biomarker. Its unique structure and function, as well as its involvement in the regulation of inflammation and infection, make it an attractive target for researchers to study.

Conclusion

In conclusion, DEFB107A is a protein that is expressed in a variety of tissues and is involved in the regulation of inflammation and infection. Its unique structure and function, as well as its potential as a drug target or biomarker, make it an attractive target for researchers to study. Further research is needed to fully understand its role in the immune response and its potential as a therapeutic agent.

Protein Name: Defensin Beta 107A

Functions: Has antibacterial activity

The "DEFB107A Target / Biomarker Review Report" is a customizable review of hundreds up to thousends of related scientific research literature by AI technology, covering specific information about DEFB107A comprehensively, including but not limited to:
•   general information;
•   protein structure and compound binding;
•   protein biological mechanisms;
•   its importance;
•   the target screening and validation;
•   expression level;
•   disease relevance;
•   drug resistance;
•   related combination drugs;
•   pharmacochemistry experiments;
•   related patent analysis;
•   advantages and risks of development, etc.
The report is helpful for project application, drug molecule design, research progress updates, publication of research papers, patent applications, etc. If you are interested to get a full version of this report, please feel free to contact us at BD@silexon.ai

More Common Targets